Michael F Mckenna

US Patent:

57874522, Jul 28, 1998

Filed:

May 21, 1996

Appl. No.:

8/651100

Inventors:

Michael G. McKenna - Oakland CA

Assignee:

Sybase, Inc. - Emeryville CA

International Classification:

G06F 1721

US Classification:

707536

Abstract:

A system providing improved National Language Support (NLS) in application programs is described. The system employs normalized Unicode data with generic transformation structures having locale overlays. Methods are described for navigating the structures during system operation, for effecting various transformation processes using locale-specific information. The locale-specific information is maintained in the structures as external data files. Since the data files are read in at runtime, the underlying binary files which comprise the program need not be modified for updating the program to support a new locale. The approach provides extensibility to applications with National Language Support. Additionally, increased portability is provided, since manipulation of the underlying data remains unchanged regardless of the underlying platform. Program maintenance is also decreased, since engineers need only maintain a single core.

US Patent:

57583145, May 26, 1998

Filed:

May 21, 1996

Appl. No.:

8/646782

Inventors:

Michael G. McKenna - Oakland CA

Assignee:

Sybase, Inc. - Emeryville CA

International Classification:

G06F 1727

US Classification:

704 8

Abstract:

A system providing improved National Language Support (NLS) in application programs is described. The system employs normalized Unicode data with generic transformation structures having locale overlays. Methods are described for navigating the structures during system operation, for effecting various transformation processes using locale-specific information. The locale-specific information is maintained in the structures as external data files. Since the data files are read in at runtime, the underlying binary files which comprise the program need not be modified for updating the program to support a new locale. The approach provides extensibility to applications with National Language Support. Additionally, increased portability is provided, since manipulation of the underlying data remains unchanged regardless of the underlying platform. Program maintenance is also decreased, since engineers need only maintain a single core.

US Patent:

20200229286, Jul 16, 2020

Filed:

Jan 10, 2020

Appl. No.:

16/740332

Inventors:

- Berkeley CA, US
Collin James Palmer - San Mateo CA, US
David Brian Lindell - Stanford CA, US
Michael Pickett McKenna - Atherton CA, US

Assignee:

Lexi Devices, Inc. - Berkeley CA

International Classification:

H05B 47/125
H04L 12/28
G06K 9/00
G06K 9/62
H05B 47/12
G06N 3/08

Abstract:

During operation, a computer provides, based at least in part on an initial lighting preference of an individual, instructions specifying initial lighting states of one or more lights in a lighting configuration in an environment, where an initial lighting state of a given light includes an intensity and a color of the given light. Then, the computer receives sensor data specifying a non-verbal physical response of the individual to initial lighting states. Moreover, the computer determines, based at least in part on the non-verbal physical response, a type of reaction of the individual to the initial lighting state. Next, the computer selectively modifies, based at least in part on a lighting behavior history of the individual and the determined type of reaction, the initial lighting preference of the individual to obtain an updated lighting preference.

US Patent:

20180275140, Sep 27, 2018

Filed:

Nov 28, 2017

Appl. No.:

15/824641

Inventors:

- Frisco CA, US
Michael P. McKenna - Oakland CA, US
Patrick A. Arensdorf - Palo Alto CA, US

International Classification:

G01N 33/68
C12Q 1/6883

Abstract:

Disclosed are methods of identifying subjects with osteoporosis or osteopenia, subjects at risk for developing osteoporosis, osteopenia, and bone fractures, methods of evaluating the effectiveness of osteoporosis treatments in subjects with osteoporosis or osteopenia, and methods of selecting therapies for treating osteoporosis or osteopenia, using biomarkers.

US Patent:

20170261520, Sep 14, 2017

Filed:

May 23, 2017

Appl. No.:

15/602502

Inventors:

- Frisco TX, US
Michael P. McKenna - Oakland CA, US
Patrick A. Arensdorf - Palo Alto CA, US

International Classification:

G01N 33/68
G01N 33/74
G06F 19/00

Abstract:

Disclosed are methods of identifying subjects with arteriovascular disease, subjects at risk for developing arteriovascular disease, methods of differentially diagnosing diseases associated with arteriovascular disease from other diseases or within sub-classifications of arteriovascular disease, methods of evaluating the risk of arteriovascular events in patients with arteriovascular disease, methods of evaluating the effectiveness of treatments in subjects with arteriovascular disease, and methods of selecting therapies for treating arteriovascular disease.

US Patent:

20170205430, Jul 20, 2017

Filed:

Apr 5, 2017

Appl. No.:

15/479694

Inventors:

- Frisco CA, US
Michael P. McKenna - Oakland CA, US
Patrick A. Arensdorf - Palo Alto CA, US

International Classification:

G01N 33/68
C12Q 1/68

Abstract:

Disclosed are methods of identifying subjects with osteoporosis or osteopenia, subjects at risk for developing osteoporosis, osteopenia, and bone fractures, methods of evaluating the effectiveness of osteoporosis treatments in subjects with osteoporosis or osteopenia, and methods of selecting therapies for treating osteoporosis or osteopenia, using biomarkers.

US Patent:

20150346218, Dec 3, 2015

Filed:

May 5, 2015

Appl. No.:

14/704286

Inventors:

- Richmond VA, US
Michael P. McKenna - Oakland CA, US
Patrick A. Arensdorf - Palo Alto CA, US

International Classification:

G01N 33/68
G06F 19/00

Abstract:

Disclosed are methods of identifying subjects with arteriovascular disease, subjects at risk for developing arteriovascular disease, methods of differentially diagnosing diseases associated with arteriovascular disease from other diseases or within sub-classifications of arteriovascular disease, methods of evaluating the risk of arteriovascular events in patients with arteriovascular disease, methods of evaluating the effectiveness of treatments in subjects with arteriovascular disease, and methods of selecting therapies for treating arteriovascular disease.